Page results
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
This information will give you an overview of BCG immunotherapy, how it is given and side effects it may cause.
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease.
-
Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.
-
UCLH will play a vital role in a new respiratory virus study.
File results
-
FOI/2022/0385 - Stillbirths and infant deaths
-
FOI/2022/0386 - Permanent/ International Recruitment for medical and non medical staff
-
FOI/2022/0392 - Replacement of patient trolleys
-
FOI/2022/0393 - COVID-19 patient treatment between 16/03/2020 - 16/06/2020
-
FOI/2022/0399 - Staff networks at the Trust
-
FOI/2022/0402 - Breast Cancer patients (any stage) treatments
-
FOI/2022/0405 - Treatments C1-esterase inhibitor & immunoglobulin treatments
-
FOI/2022/0408 - Date UCLH became smoke-free
-
FOI/2022/0412 - Mental health inpatient facilities
-
FOI/2022/0413 - Head and neck cancer and urothelial cancer patients treatment and clinical trials